Get the Stockscreener App
1.10
5.77%
0.06
Pre-market:
1.14
0.04
+3.64%
Hyperfine Inc stock is traded at $1.10, with a volume of 241.33K.
It is up +5.77% in the last 24 hours and up +7.84% over the past month.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
See More
Previous Close:
$1.04
Open:
$1.06
24h Volume:
241.33K
Relative Volume:
0.41
Market Cap:
$106.89M
Revenue:
$11.03M
Net Income/Loss:
$-44.24M
P/E Ratio:
-1.7742
EPS:
-0.62
Net Cash Flow:
$-42.61M
1W Performance:
-1.79%
1M Performance:
+7.84%
6M Performance:
-5.98%
1Y Performance:
-35.67%
1-Day Range:
$1.06
$1.14
1-Week Range:
$1.035
$1.18
52-Week Range:
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Name
Hyperfine Inc
Sector
Industry
Phone
866-796-6767
Address
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.10 | 101.06M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
110.83 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
358.29 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
102.90 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.27 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.71 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-31-22 | Initiated | Evercore ISI | Outperform |
| Apr-14-22 | Initiated | Wells Fargo | Overweight |
Hyperfine Inc Stock (HYPR) Latest News
Hyperfine’s HYPR Stock: Can Portable MRI’s Under-the-Radar Disruptor Turn Volatility Into a Brea - AD HOC NEWS
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Increases By 46.4% - MarketBeat
Analyst Calls: Does Hyperfine Inc have a sustainable dividendBond Market & Low Volatility Stock Recommendations - baoquankhu1.vn
Hyperfine’s portable MRI shows promise in detecting small strokes By Investing.com - Investing.com Australia
Hyperfine’s portable MRI shows promise in detecting small strokes - Investing.com
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities - The AI Journal
Quarterly Earnings: Is Hyperfine Inc stock showing strong momentum2025 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 87% over the last five years - Yahoo Finance
Hyperfine’s portable brain MRI shows high concordance with standard MRI By Investing.com - Investing.com Nigeria
Hyperfine (HYPR) Receives a Buy from Lake Street - The Globe and Mail
Study Shows Economic Benefits of Swoop System Use in Acute Hospital Care - Medical Product Outsourcing
Quarterly Risk: Is Hyperfine Inc affected by consumer sentimentOptions Play & Real-Time Sentiment Analysis - baoquankhu1.vn
Growth Review: Is Hyperfine Inc gaining market shareTrade Performance Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Institution Moves: How does ALEX perform in inflationary periodsJuly 2025 Selloffs & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics - 01net
Insider Trends: Is Hyperfine Inc affected by consumer sentimentMarket Activity Recap & Fast Gain Stock Tips - baoquankhu1.vn
Hyperfine’s portable brain MRI shows high concordance with standard MRI - Investing.com
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Up 29.5% in December - MarketBeat
Market Trends: Is KRRO currently under institutional pressure2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
Energy Moves: How does Hyperfine Inc score in quality rankings2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
Hyperfine Enrolls 1st Patient in Contrast PMR Study - Medical Product Outsourcing
Hyperfine begins clinical study for contrast-enhanced portable MRI By Investing.com - Investing.com Nigeria
Hyperfine Enrolls First Patient in Contrast-Enhanced Portable MRI Study - marketscreener.com
Hyperfine, Inc. Announces Enrollment of First Patient in Study to Expand Intended Use of Swoop System with Contrast Agents - marketscreener.com
Hyperfine begins clinical study for contrast-enhanced portable MRI - Investing.com
Hyperfine announces enrollment of first patient in study to expand intended use of the Swoop® system with contrast agents - marketscreener.com
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents - The AI Journal
Revenues Tell The Story For Hyperfine, Inc. (NASDAQ:HYPR) As Its Stock Soars 34% - simplywall.st
Treasury Yields: Is Hyperfine Inc stock showing strong momentumJuly 2025 Volume & Fast Moving Stock Watchlists - baoquankhu1.vn
Hyperfine announces workforce reduction to streamline operations - MSN
Indian Regulators Approve Hyperfine’s Swoop System - Medical Product Outsourcing
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 - Investing.com Canada
Hyperfine Announces Strong Preliminary Q4 2025 Revenue Growth - The Globe and Mail
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 By Investing.com - Investing.com South Africa
Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M - TipRanks
Health tech firm Hyperfine prelim Q4 revenue rises 127% on Swoop system adoption - TradingView — Track All Markets
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Published on: 2026-01-10 20:32:17 - Улправда
Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence - MSN
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - FinancialContent
Can Hyperfine Inc. stock maintain growth trajectoryCEO Change & Safe Entry Trade Signal Reports - ulpravda.ru
Is Hyperfine Inc. stock attractive for long term wealth buildingWeekly Trade Review & Daily Entry Point Trade Alerts - ulpravda.ru
Is Hyperfine Inc. stock supported by strong cash flowsWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - ulpravda.ru
Hyperfine (HYPR) Price Target Increased by 20.00% to 1.73 - MSN
How Hyperfine Inc. stock valuations compare to rivalsAutomated Trading Signals & Analyze Your Portfolio Risk in Seconds - Улправда
Can Hyperfine Inc. stock hit analyst price targets2026 world cup usa national team quarterfinals goalkeepers high defensive line odds analysis insights - ulpravda.ru
Star TribuneHyperfine, Inc.Class A Common Stock (Nasdaq:HYPR) Price Chart - FinancialContent
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care - 01net
Portable MRI system shows economic benefits for hospitals By Investing.com - Investing.com South Africa
Hyperfine Inc Stock (HYPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
2.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):